Skip to Main Content

Author Details

Xiaoqing Chen
QIMR Berghofer Medical Research Institute
1999
113
41
PMIDPaper TitleJournal TitlePublished Year
35263119TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.J Clin Oncol2022
35263119TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.J Clin Oncol2022
34093841Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics.J Cancer2021
33968723Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.Front Oncol2021
34093841Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics.J Cancer2021
34454403Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.EBioMedicine2021
34454403Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.EBioMedicine2021
33968723Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.Front Oncol2021
32638235Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.Breast Cancer Res Treat2020
32638235Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.Breast Cancer Res Treat2020
31168460Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.Ann Transl Med2019
30135485Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet2019
31168460Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.Ann Transl Med2019
30135485Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet2019
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
27171545Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.Genet Med2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
27171545Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.Genet Med2017
28145423Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28145423Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet2017
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26711112Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.Nat Genet2016
26711112Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.Nat Genet2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26075790Genome-wide significant risk associations for mucinous ovarian carcinoma.Nat Genet2015
26075790Genome-wide significant risk associations for mucinous ovarian carcinoma.Nat Genet2015
24957074ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.J Natl Cancer Inst2014
24810093Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.Sci Rep2014
24957074ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.J Natl Cancer Inst2014
24810093Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.Sci Rep2014
23535649Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.Nat Commun2013
23756864Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer.Br J Cancer2013
23917080ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Gynecol Oncol2013
23535649Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.Nat Commun2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23917080ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Gynecol Oncol2013
23756864Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer.Br J Cancer2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
22348646Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.Breast Cancer Res2012
22351618Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2012
  • 1 - 50 of 226

Recommended Authors

Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 22
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 23
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Sander Canisius
The Netherlands Cancer Institute
Career Start Year 2011
Number of shared co-authors 74
Maria P Intermaggio
University of New South Wales
Career Start Year 2010
Number of shared co-authors 92
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 39
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 34
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 35
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Career Start Year 2004
Number of shared co-authors 2
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 22
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Career Start Year 2003
Number of shared co-authors 30
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
Oleg Oszurek
Pomeranian Medical University
Career Start Year 2001
Number of shared co-authors 86
Sevtap Savas
Memorial University
Career Start Year 1999
Number of shared co-authors 3
Wanqing Wen
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 53
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 8
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 22
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
John S Witte
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 54
Meredith Yeager
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 65
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 119
Qingyi Wei
South China University of Technology
Career Start Year 1992
Number of shared co-authors 26
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 40
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 9
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 25
Ming K Lee
University of Washington
Career Start Year 1988
Number of shared co-authors 16
Zsofia Kote-Jarai
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 113
Elizabeth M Gillanders
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 56
Daniela Seminara
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 72
Mary-Claire King
University of Washington
Career Start Year 1975
Number of shared co-authors 35

Collaborators

Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 105
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 72
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 71
Douglas F Easton
University of Cambridge
Co-authored papers 61
Fergus J Couch
Mayo Clinic
Co-authored papers 46
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 40
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 39
Graham G Giles
Co-authored papers 38
Irene L Andrulis
University of Toronto
Co-authored papers 35
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 31
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 31
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 31
Susan M Domchek
Co-authored papers 27
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 27
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 27
Hoda Anton-Culver
University of California irvine
Co-authored papers 25
Jan Lubinski
Pomeranian Medical University
Co-authored papers 25
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 25
Esther M John
Co-authored papers 25
David E Goldgar
University of Utah
Co-authored papers 24
Roger L Milne
Co-authored papers 24
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 24
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 24
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 24
Alison M Dunning
Co-authored papers 22
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 21
Diether Lambrechts
Co-authored papers 21
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 21
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 20
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 19
Release 1.2